Phreesia, Inc. (0A23.L)
USD 28.5
(-1.96%)
USD 28.5
(-1.96%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -131.77 Million USD | 25.36% |
| 2023 | -176.55 Million USD | -51.14% |
| 2022 | -116.81 Million USD | -355.05% |
| 2021 | -25.67 Million USD | -114.09% |
| 2020 | -11.99 Million USD | -26.31% |
| 2019 | -9.49 Million USD | 34.76% |
| 2018 | -14.55 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -37.9 Million USD | 4.8% |
| 2024 FY | -133.37 Million USD | 24.46% |
| 2024 Q2 | -36.95 Million USD | 2.5% |
| 2024 Q3 | -32.04 Million USD | 13.29% |
| 2024 Q4 | -29.58 Million USD | 7.67% |
| 2023 Q2 | -46.33 Million USD | 8.42% |
| 2023 FY | -176.55 Million USD | -51.14% |
| 2023 Q4 | -39.81 Million USD | -0.01% |
| 2023 Q3 | -39.81 Million USD | 14.08% |
| 2023 Q1 | -50.59 Million USD | -8.53% |
| 2022 Q1 | -10.65 Million USD | -28.64% |
| 2022 Q2 | -23.8 Million USD | -123.49% |
| 2022 Q3 | -35.74 Million USD | -50.12% |
| 2022 Q4 | -46.61 Million USD | -30.43% |
| 2022 FY | -116.81 Million USD | -355.05% |
| 2021 Q4 | -8.28 Million USD | -35.44% |
| 2021 Q3 | -6.11 Million USD | 3.11% |
| 2021 Q2 | -6.31 Million USD | -27.06% |
| 2021 FY | -25.67 Million USD | -114.09% |
| 2021 Q1 | -4.96 Million USD | -6.29% |
| 2020 Q1 | -4.25 Million USD | -28.98% |
| 2020 FY | -11.99 Million USD | -26.31% |
| 2020 Q3 | -2.23 Million USD | 46.12% |
| 2020 Q4 | -4.67 Million USD | -109.41% |
| 2020 Q2 | -4.14 Million USD | 2.68% |
| 2019 Q2 | -1.24 Million USD | 34.61% |
| 2019 Q1 | -1.9 Million USD | 0.0% |
| 2019 Q3 | -3.03 Million USD | -143.1% |
| 2019 FY | -9.49 Million USD | 34.76% |
| 2019 Q4 | -3.29 Million USD | -8.65% |
| 2018 FY | -14.55 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Accuray Incorporated | 504 Thousand USD | 26245.437% |
| Align Technology, Inc. | 643.33 Million USD | 120.483% |
| Elevance Health Inc. | 133.96 Billion USD | 100.098% |
| AxoGen, Inc. | -21.46 Million USD | -513.983% |
| Boston Scientific Corporation | 2.34 Billion USD | 105.624% |
| CVS Health Corporation | 13.74 Billion USD | 100.959% |
| Cardinal Health, Inc. | 1.24 Billion USD | 110.601% |
| Centene Corporation | 2.93 Billion USD | 104.497% |
| DaVita Inc. | 1.6 Billion USD | 108.222% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 101.369% |
| Hologic, Inc. | 970.2 Million USD | 113.582% |
| Humana Inc. | 4.01 Billion USD | 103.284% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 112.011% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | 118.161% |
| Masimo Corporation | 136.5 Million USD | 196.537% |
| McKesson Corporation | 3.9 Billion USD | 103.371% |
| Patterson Companies, Inc. | 252.92 Million USD | 152.1% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 110.442% |
| ResMed Inc. | 1.31 Billion USD | 109.984% |
| Henry Schein, Inc. | 615 Million USD | 121.427% |
| Teladoc Health, Inc. | -248.55 Million USD | 46.984% |
| Universal Health Services, Inc. | 1.17 Billion USD | 111.211% |
| Veeva Systems Inc. | 429.33 Million USD | 130.692% |
| Baxter International Inc. | 390 Million USD | 133.788% |
| Becton, Dickinson and Company | 2.11 Billion USD | 106.242% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 107.458% |
| Danaher Corporation | 5.38 Billion USD | 102.449% |
| Stryker Corporation | 3.88 Billion USD | 103.389% |
| Medtronic plc | 5.14 Billion USD | 102.562% |